Mkt Cap (₹ Cr.)
Face Value (₹)
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Cipla Ltd. Share Price Updates
Cipla Ltd. Earnings(Figures in Rs. Cr.)
Cipla Ltd. Stock Performance
Cipla Ltd. Financial Performance
Cipla Ltd. Financial Comparison with peers
Mutual Fund Ownership
(in ₹ Cr)
About Cipla Ltd.
Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 59135.95 Crore) operating in Pharmaceuticals sector.
Cipla Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 12220.22 Crore to Sales Value (96.53 % of Total Sales), Export Incentives which contributed Rs 249.96 Crore to Sales Value (1.97 % of Total Sales), Other Operating Revenue which contributed Rs 103.40 Crore to Sales Value (0.81 % of Total Sales), Royalty Income which contributed Rs 56.02 Crore to Sales Value (0.44 % of Total Sales) and Scrap which contributed Rs 29.55 Crore to Sales Value (0.23 % of Total Sales)for the year ending 31-Mar-2020.
For the quarter ended 30-06-2020, the company has reported a Consolidated sales of Rs 4276.89 Crore, down -.57 % from last quarter Sales of Rs 4301.60 Crore and up 9.82 % from last year same quarter Sales of Rs 3894.46 Crore Company has reported net profit after tax of Rs 571.43 Crore in latest quarter.
The company’s top management includes Dr.Peter Mugyenyi, Ms.Punita Lal, Ms.Naina Lal Kidwai, Mr.Umang Vohra, Mr.S Radhakrishnan, Mr.Peter Lankau, Mr.M K Hamied, Mr.Ashok Sinha, Mr.Adil Zainulbhai, Dr.Y K Hamied, Ms.Samina Vaziralli. Company has Walker Chandiok & Co. LLP as its auditors As on 30-06-2020, the company has a total of 806,271,001 shares outstanding.